The Effects of MLS LASER Therapy in Patients With Chronic Nonspecific Low Back Pain

NCT ID: NCT05870826

Last Updated: 2023-05-25

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-03-21
• Study Completion Date: 2023-03-21

Brief Summary

Non-specific cronic low back pain is very common condition affecting 80-85% of adults. The most common therapies for low back pain are: patient education, excercise and physical therapy. High intensity laser therapy has been shown to be an effective treatment to improve sympthoms in patient with non-specific low back pain when combined wth exercise.

The aim of this study is to assess the effects of a multi-wave locked system laser therapy in patient with non-specif low back pain when administered alone.

Detailed Description

Chronic nonspecific low back pain, given its high prevalence globally and the disability resulting from it, results in significant deterioration in quality of life and substantial both social and economic costs. The determinants are predominantly biological, in particular musculoskeletal alterations of the lumbar region, but psychosocial factors also contribute significantly to the manifestation of the disorder.

Patients with chronic nonspecific low back pain are characterized by pain intensity sometimes disabling, a reduction in lumbar range of motion (ROM) and the frequent absence of flexion-relaxation phenomenon (FRP). Both high-power and low-power laser therapy, especially when included in a multidimensional rehabilitation plan, seems effective in improving both pain and function of affected patients. MLS (Multiwave Locked System) laser therapy is an innovative high-power technology characterized by the combined and synchronized emission of laser light at two wavelengths (a continuous emission with a wavelength wavelength of 808 nm and a pulsed emission at 905 nm) and its efficacy in the treatment of chronic nonspecific low back pain is still unknown.

This work aims to study the effects of MSL laser therapy on pain, disability disability, lumbar ROM and muscle activity in a homogeneous group of patients with from chronic nonspecific low back pain. Although the literature shows that the combination of exercise with laser therapy yields better results in terms of both pain reduction and functional recovery, in this study we chose not to use any combination of treatments, in order to evaluate the effectiveness of MLS laser therapy alone in the treatment of chronic nonspecific low back pain.

To isolate the specific results of MLS laser therapy, it is intended to compare it with a placebo, represented by a device apparently identical in morphology and behavior to that delivering the laser and emitting visible light of similar appearance, by means of a clinical trial double-blind prospective randomized controlled trial. The double-blind design is adhered to because the type of laser therapy employed with the protocol followed, despite the effects tissue biology highlighted in the literature, is not able to make the patient feel any heat sensation during the session. 31 This is the first study in the literature aimed at analyzing the possible effects determined by the use of MLS laser therapy in chronic nonspecific low back pain: this investigation is conducted with an integrated methodology, using standardized and validated measures for pain intensity and disability, combined with kinematic and electromyography of high technological value.

Conditions

Non-specific Low Back Pain

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Sham laser therapy

The control group (PL group) is subjected to a laser sham (placebo), employing a device identical to the one under investigation but lacking the laser emission capability, and the same mode of administration in terms of time and place. Both the sham laser and the test device emit visible light of the same color and are not distinguishable in any way.

Group Type: SHAM_COMPARATOR

Sham laser therapy

Intervention Type: OTHER

Sham laser therapy

Laser therapy

The MLS group receives MLS synchronized diode laser therapy emitted by the MLS M8 robotic device (ASA, Italy).

MLS M8 (ASA, Arcugnano, Italy), a Class IV (high-power) laser approved by the Food Drug Administration (FDA) and CE certified, characterized by a combined, synchronized two-wavelength (CPW) emission: a continuous emission with a wavelength of 808 nm and a pulsed emission at 905 nm.

The duration of each session is 5 min 45 sec.seconds, delivering a total energy of 1500 J and an energy dose of 5 J/cm2, for an area of 300 cm2.

The robotic device is placed in the lumbar area, oriented on the muscles erector spinae and quadratus lumborum. The target area set on the device is "lumbar area." The parameters set on the device are "Synchronized Emission of Continuous Pulsed Wave (CPW)," "intensity of 100%," "time of 5 minutes and 45 seconds," and "area of 1x300 cm2."

Group Type: EXPERIMENTAL

Multiwave locked system laser therapy

Intervention Type: OTHER

High intensity laser therapy

Interventions

Multiwave locked system laser therapy

High intensity laser therapy

Intervention Type: OTHER

Sham laser therapy

Sham laser therapy

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Chronic low back pain (> 3 months)
• Lack of effectivness of previous conservative therapies for low back pain
• Body mass index < 30
• Preserved cognitive ability to fully understand and observe indications received by medical personnel
• Ability to understand and give an informed consent

Exclusion Criteria

• Spine surgery
• Spinal hernia
• spondylolisthesis
• Spinal infections
• Severe spine deformities
• Neural diseases
• Rheumatic diseases
• Diabetes
• Psychiatric diseases
• Vascular diseases
• Cancer
• Infectious diseases
• Kidney stones
• Skin abrasion
• Pregnancy or breastfeeding
• Recent injuries
• Known sensibility to Laser therapy
• Epilepsy
• Anticoagulant therapy
• Pacemaker
• hemorrhagic diathesis
• Photosensitizing drugs
• Kown Photosensibility
• Low back Tattoos
• Steroid injections in the previous 3 weeks
• Antinflammatory or pain drugs
• HIV positive
• Neuro-stimulation implanted systems
• Tissue with ischemia in the low back

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Istituto Ortopedico Rizzoli

OTHER

Sponsor Role: lead

Responsible Party

Mariagrazia Benedetti

Head of the Unit of Physical Medicine and Rehabilitation

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Maria Grazia Benedetti

Role: PRINCIPAL_INVESTIGATOR

Istituto Ortopedico Rizzoli

Locations

IRCCS-Istituto Ortopedico Rizzoli

Bologna, , Italy

Countries

Italy

Other Identifiers

0012596

Identifier Type: -

Identifier Source: org_study_id